Business Context and Reporting Period
Kronos Worldwide, Inc. (KRO) filed a Current Report on Form 8-K on January 23, 2024. The filing announces a debt exchange offer, a consent solicitation, and provides a preliminary, unaudited update on financial results for the fourth quarter of 2023 and outlook for 2024.
Key Financial Metrics
Fourth Quarter 2023 Preliminary Results
- Net Sales: Expected range of $390 million to $410 million.
- EBITDA: Expected range of $5 million to $8 million (non-GAAP).
- Capital Expenditures: Expected range of $4 million to $5 million.
- Cash and Liquidity: Cash, cash equivalents, and restricted cash between $195 million and $205 million as of December 31, 2023. Total liquidity (including committed amounts under the $225 million Global Revolver) is between $420 million and $430 million.
- Production and Sales Volumes: TiO2 sales volumes expected at approximately 106,000 metric tons; production volumes at approximately 105,000 metric tons.
Material Changes vs. Prior Period
- Sales Growth: Q4 2023 net sales are projected to increase from $342 million in Q4 2022, driven by a 29% increase in TiO2 sales volumes, partially offset by lower average selling prices.
- EBITDA Improvement: Q4 2023 EBITDA is expected to turn positive ($5M-$8M) compared to a loss of $(8.2) million in Q4 2022 and $(12.7) million in Q3 2023.
- One-Time Charges: Q4 2023 EBITDA includes approximately $7 million in charges for workforce reductions and a $3 million charge for the write-off of engineering costs.
- Capital Expenditures: Expected to decrease significantly from $18.8 million in Q4 2022 and $8.2 million in Q3 2023.
Guidance, Outlook, and Corporate Actions
Debt Restructuring (Exchange Offer)
The Company launched an exchange offer to swap 3.75% Senior Secured Notes due 2025 ("Old Notes") for a combination of new 9.50% Senior Secured Notes due 2029 ("New Notes") and cash. The offer targets up to €325 million of Old Notes, with a minimum tender requirement of €275 million. A concurrent consent solicitation seeks to amend restrictive covenants on the Old Notes.
Funding
Cash payments for the exchange offer are anticipated to be funded by a €50 million subordinated, unsecured loan from Contran Corporation (indirect majority shareholder). This loan will bear interest at 2% above the New Notes rate and mature in 5.5 years.
2024 Outlook
- Demand: Management expects consumer demand to improve in 2024, with customer destocking largely complete. Q1 2024 sales volumes are expected to exceed Q1 2023 levels.
- Production: Production volumes in 2024 are expected to be higher than 2023, though below full practical capacity of 556,000 metric tons.
- Pricing: Pricing pressures from Chinese imports into Europe are expected to be mitigated, with potential industry pricing upside.
- Cost Savings: Targeted workforce reductions and process improvements are expected to yield approximately $31 million in annual cost savings starting in 2024 ($11 million from workforce, $20 million from technology/process).
Risks and Contingencies
The filing includes standard forward-looking statement disclaimers. Key risks include supply and demand fluctuations, raw material costs, currency exchange rate volatility, regulatory changes regarding TiO2, and the successful completion of the exchange offer conditions.
Investor Verification Checklist
- Verify the final acceptance rate of the Exchange Offer and whether the €275 million minimum tender threshold was met.
- Confirm the final audited Q4 2023 and full-year 2023 financial results, specifically the reconciliation of the preliminary EBITDA to GAAP net income.
- Monitor the execution of the €50 million subordinated loan from Contran Corporation and its impact on the capital structure.
- Track Q1 2024 sales volumes and pricing trends to validate the management's outlook on destocking completion and demand recovery.
- Review the final terms of the indenture amendments resulting from the consent solicitation.